CNN Legal View With Ashleigh Banfield November 26, 2015 17:12:00
New once-a-day namzaric™. vo: new namzaric is approved for moderate to severe alzheimers disease in patients who are currently taking, and can continue to take certain doses of both namenda and donepezil. new namzaric is the first and only treatment to combine 2 proven alzheimers medicines into a single once-a-day capsule that works 2 ways to fight the symptoms of moderate to severe alzheimers disease. once-a-day namzaric may improve cognition and overall function and may slow the worsening of...
Source: archive.org